Interrupting DOAC therapy before surgery can increase the risk for thrombotic events, whereas continuing these medications can increase bleeding risk. Clinicians should adopt a balanced and ...
A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which ...